Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival

American Journal of Pathology

Volumn 145, Issue 2, 1994, Pages 301-309

  Campo, Elías ^a,b   Muñoz, José ^a,b   Miquel, Rosa ^a,b   Palacín, Antonio ^a,b   Cardesa, Antonio ^a,b   Sloane, Bonnie F ^c   Emmert Buck, Michael R ^d,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; POLYCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; COLON ADENOMA; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME INDUCTION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TUMOR CELL;

ADENOMA; CARCINOMA; CATHEPSIN B; COLON; COLORECTAL NEOPLASMS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; STAINING AND LABELING; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0028145293     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gottesman MM: Introduction: do proteases play a role in cancer? Semin Cancer Biol 1990, 1:97-98
2. Liotta LA, Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1990, 1:99-106
3. Matrisian LM, Bowden TG: Stromelysin/transin and tumor progression. Semin Cancer Biol 1990, 1:107-115
4. Sloane BF: Cathepsin B and cystatins: evidence for a role in cancer progression. Semin Cancer Biol 1990, 1:137-152
5. Kane SE, Gottesman MM: The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990, 1:127-136
6. Rochefort H: Biological and clinical significance of cathepsin D in breast cancer. Semin Cancer Biol 1990, 1:153-160
7. Blasi F, Verde P: Urokinase-dependent cell surface proteolysis and cancer. Semin Cancer Biol 1990, 1:117-126
8. Maciewicz RA, Wotton SF, Eherington DJ, Duane VC: Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett 1990, 269:189-193
9. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF: Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 1992, 282:273-278
10. Cohen AM, Shank B, Friedman MA: Colorectal cancer. In Cancer: Principles and Practice of Oncology. Edited by DeVita VT, Helman S, Rosenberg SA. Philadelphia, PA, B Lippincott Company, Vol 1, 1989, pp 896-964
11. r 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991, 51:439-444
12. Maciewicz RA, Wardale JR, Etherington DJ, Paraskeva C: Immunodetection of cathepsins B and L present in and secreted from human premalignant and malignant colorectal tumour cell lines. Int J Cancer 1989, 43:478-486
13. Keppler D, Fondaneche MC, Dalet-Fumeron V, Pagano M, Burtin P: Immunohistochemical and biochemical study of a cathepsin B like proteinase in human colonic cancers. Cancer Res 1988, 48:6855-6862
14. Hermanek P, Sobin LH, eds: UICC TNM Classification of Malignant Tumors. 4th ed, 2nd rev. Berlin, Springer-Verlag, 1992
15. Morson B, Sobin L: Histological Typing of Intestinal Tumors: International Histological Classification of Tumors, n 15. Geneva, WHO, 1976
16. Moin K, Day NA, Sameni M, Hasnain S, Hirama T, Sloane BF: Human tumour cathepsin B: comparison with normal human liver cathepsin B. Biochem J 1992, 285:427-434
17. Sloane BF, Sameni M, Cao L, Rozhin J, Moin K: Altered regulation of cathepsin B in malignancy. In Biological Functions of Proteases and Inhibitors. Edited by Katunama N, Suzuki K, Travis J, Fritz H. Tokyo, Japan Scientific Societies Press, 1994
18. Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53: 457-481
19. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966, 50:163-170
20. Ossowski L, Clunie G, Masucci MT, Blasi F: In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol 1991, 115:1107-1112
21. Pyke C, Kristensen P, Ralfkaier E, Grondahl-Hansen J, Eriksen J, Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991, 138:1059-1067
22. Baici A, Knopfel M, Keist R: Tumor-host interactions in the rabbit V2 carcinoma: stimulation of cathepsin B in host fibroblasts by a tumor-derived cytokine. Invasion Metastasis 1988, 8:143-158
23. Poulsom R, Pignatelli M, Stetler-Stevenson WG: Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992, 141:389-396
24. Gray ST, Wilkins RJ, Yun K: Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 1992, 141:301-306
25. Recklies AD, Tiltman KJ, Stoker TAM, Poole AR: Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res 1980, 40:550-556
26. Recklies AD, Poole AR, Mort JS: A cysteine proteinase secreted from human breast tumors is immunologically related to cathepsin B. Biochem J 1982, 207: 633-636
27. Mort JS, Leduc M, Recklies A: A latent thiol proteinase from ascitic fluid of patients with neoplasia. Biochim Biophys Acta 1981, 662:173-180
28. Mason RW, Gal S, Gottesman MM: The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L. Biochem J 1987, 248:449-454
29. Erickson AH: Biosynthesis of lysosomal endopeptidases. J Cell Biochem 1989, 40:31-41
30. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV: Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sei USA 1986, 83:2483-2487
31. Rozhin J, Robinson D, Stevens MA, Lah TT, Honn KV, Ryan RE, Sloane BF: Properties of a plasma membrane associated cathepsin B-like cysteine proteinase in metastatic melanoma variants. Cancer Res 1987, 47:6620-6628
32. Forster SJ, Talbot IC, Clayton DG, Critchley DR: Tumour basement membrane (BM) laminin in adenocarcinoma of the rectum: an immunohistochemical study of biologic and clinical significance. Int J Cancer 1986, 37:813-817
33. Havenitt MG, Arends JW, Simon R, Volovics A, Wiggers T, Bosman FT: Type IV collagen immunoreactivity in colorectal cancer. Cancer 1988, 62:2207-2211
34. Hewitt RE, Powe DG, Griffin NR, Turner DR: Relationships between epithelial basement membrane staining patterns in primary colorectal carcinomas and the extent of tumour spread. Int J Cancer 1991, 48:855-860
35. Sheahan K, Shuja S, Murnane MJ: Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 1989, 49:3809-3814
36. Shuja S, Sheahan K, Murnane MJ: Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int J Cancer 1991, 49: 341-346
37. Murnane MJ, Sheahan K, Ozdemirli M, Shuja S: Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 1991, 51:1137-1142